$123.37 0.38 (0.31%)
Market Cap 17.84 Billion
ResMed is one of the largest global respiratory medical devices companies, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns 65% of revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payor in the out-of-hospital setting.
EPS 0.74 P/E Ratio 31.80
Previous Earnings Thu, May 2, 2019
Latest Earnings Thu, Jul 25, 2019 (In 8 days)
Yield 1.20% / $1.48
Ex-Date Wed, May 8, 2019 (70 days ago)
Pay Date Thu, Jun 13, 2019
|Symbol||Price||Day %||YTD %|
This list of trending stocks may change throughout the trading day.